Tag Archives: John Dalli

Clinical Trials Caught in Fallout of EC Health Minister Departure

The abrupt departure of Europe’s health commissioner continues to resonate across the European Union – and to leave plans for new clinical trials legislation without a patron, writes Peter O’ Donnell of Applied Clinical Trials. John Dalli, the former Maltese finance minister, was forced out of his job as Europe’s health supremo in mid-October, over […]
Posted in Europe, Guest Blog, R&D | Also tagged , , | Leave a comment

Europe: Health Commissioner's Sudden Exit Spotlights Regulation Crisis

The sudden departure of EC Health Commissioner John Dalli tops an already difficult year for the European pharma regulators, writes Reflector. The abrupt departure of Health Commissioner John Dalli in highly controversial circumstances comes on top of an extremely difficult year for the European Medicines Agency (EMA). At the same time, one of the main […]
Posted in Strategy | Also tagged , , | Leave a comment

EU Pins Hopes on HTA Network for Consensus on Value

The European Union’s proposed health technology assessment network to encourage “cooperation and exchange of scientific information among member states” is a significant step, says Reflector. But, as far as standardizing an approach to value is concerned, will it be a damp squib?
Posted in Europe, Global, Guest Blog, pricing | Also tagged , , , , , | Leave a comment

Is Hungary Hungry Enough for Pharma?

Hungary has taken over the chair of the EU Council, but European pharma is unlikely to gain much from its surface enthusiam, writes Reflector. A new, young, and supposedly business-friendly democracy has swung into European action this month. Hungary, one of the most recent countries to join the European Union, took over the chair of […]
Posted in Europe, Global, Guest Blog, Regulatory, Strategy | Also tagged , , , | Leave a comment

EU Health Commissioner Emerges from the Dark

After a period of near invisibility, the EU’s health commissioner John Dalli has begun to make some higher profile appearance. Pharm Exec’s Europe correspondent Reflector assesses how these have been received by the pharma industry. Just before the holiday break, John Dalli, the European Union’s unobtrusive commissioner for health, has at last emerged from obscurity […]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , | 1 Comment
  • Categories

  • Meta